NEW YORK, April 27 (GenomeWeb News) - Jubilant Biosys, of Bangalore, India, said today that it has licensed its PathArt database of biochemical pathways to Genstruct for use in that company's drug discovery programs.
Genstruct will use the database to enhance its Molecular Epistemics platform for the discovery and definition of compound mechanism of action and biomarkers.
According to Jubilant, PathArt contains over 600 manually curated signaling, metabolic, and disease-specific pathways, including diseases such as cancer, arthritis, Alzheimer's, asthma, multiple sclerosis, Parkinson's, diabetes, and atherosclerosis.